New York State Common Retirement Fund Sells 1,055 Shares of Phreesia, Inc. (NYSE:PHR)

New York State Common Retirement Fund lessened its holdings in Phreesia, Inc. (NYSE:PHR) by 6.0% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,547 shares of the company’s stock after selling 1,055 shares during the period. New York State Common Retirement Fund’s holdings in Phreesia were worth $423,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Johnson Financial Group Inc. increased its position in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after acquiring an additional 896 shares during the last quarter. Quarry LP increased its position in Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after acquiring an additional 1,923 shares during the last quarter. KBC Group NV bought a new position in Phreesia during the first quarter valued at $74,000. NewEdge Advisors LLC increased its position in Phreesia by 12.1% during the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company’s stock valued at $107,000 after acquiring an additional 459 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in Phreesia by 1,023.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,660 shares of the company’s stock valued at $142,000 after acquiring an additional 5,156 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Analyst Upgrades and Downgrades

PHR has been the topic of a number of analyst reports. DA Davidson upgraded shares of Phreesia to a “strong-buy” rating in a research report on Tuesday. Canaccord Genuity Group lowered their target price on shares of Phreesia from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Thursday, May 29th. Wall Street Zen raised shares of Phreesia from a “hold” rating to a “buy” rating in a research note on Sunday, June 1st. Truist Financial boosted their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, May 29th. Finally, Citigroup reissued a “buy” rating on shares of Phreesia in a research note on Wednesday, May 28th. Eleven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $32.27.

Insider Buying and Selling

In other Phreesia news, General Counsel Allison C. Hoffman sold 1,245 shares of the stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $33,478.05. Following the completion of the sale, the general counsel directly owned 136,978 shares of the company’s stock, valued at approximately $3,683,338.42. This represents a 0.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Evan Roberts sold 1,892 shares of the stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $50,875.88. Following the sale, the chief operating officer directly owned 772,915 shares of the company’s stock, valued at approximately $20,783,684.35. The trade was a 0.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 53,804 shares of company stock valued at $1,510,733 over the last quarter. 5.50% of the stock is owned by company insiders.

Phreesia Stock Down 1.6%

NYSE:PHR opened at $26.62 on Friday. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The company has a 50-day moving average of $26.61 and a 200 day moving average of $26.43. The firm has a market cap of $1.58 billion, a PE ratio of -35.97 and a beta of 0.72. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The company had revenue of $115.94 million during the quarter, compared to analyst estimates of $115.00 million. During the same period in the prior year, the firm earned ($0.05) earnings per share. The firm’s revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, research analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.